News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb Company (BMY) Melanoma Drug Yervoy Gets EU Approval


7/14/2011 8:24:36 AM

Doctors and patient groups said it was a "quantum leap" for people with melanoma, one of the most dangerous and aggressive forms of cancer. The Therapeutic Goods Administration has approved the intravenous treatment after clinical trials showed ipilimumab can almost double the number of patients alive three years after diagnosis. "The people who are told to go home and get their affairs in order, they are the people that will benefit from this drug," Melanoma Patients Australia CEO Lisa McFadyen said.



comments powered by Disqus
   
Melanoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES